Stocks · News reference
BrainsWay To Invest $500,000 For Minority Position In Sound Minds In The Form Of Preferred, Annually Compounding Security
BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced its participation
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Jul 16, 2026, 11:34 AM
- Checked
- Jul 16, 2026, 11:34 AM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Ladenburg Thalmann Maintains Buy on BrainsWay, Raises Price Target to $18.8
Ladenburg Thalmann analyst Jeffrey Cohen maintains BrainsWay (NASDAQ:BWAY) with a Buy and raises the price target from $18 to $18.8.
Read original at benzingaBrainsWay shares are trading higher after the company reported better-than-expected Q2 sales results and raised its FY26 sales guidance above analyst estimates.
Read original at benzingaBTIG Maintains Buy on BrainsWay, Raises Price Target to $20
BTIG analyst Sam Eiber maintains BrainsWay (NASDAQ:BWAY) with a Buy and raises the price target from $18 to $20.
Read original at benzinga